Cerebral Perfusion and the Risk of Dementia: A Population-Based Study

Background: Cerebral hypoperfusion has previously been associated with mild cognitive impairment and dementia in various cross-sectional studies, but whether hypoperfusion precedes neurodegeneration is unknown. We prospectively determined the association of cerebral perfusion with subsequent cognitive decline and development of dementia. Methods: Between 2005 and 2012, we measured cerebral blood flow by 2-dimensional phase-contrast magnetic resonance imaging in participants of the population-based Rotterdam Study without dementia. We determined the association of cerebral perfusion (mL/100mL/min) with risk of dementia (until 2015) using a Cox model, adjusting for age, sex, demographics, cardiovascular risk factors, and apolipoprotein E genotype. We repeated analyses for Alzheimer disease and accounting for stroke. We used linear regression to determine change in cognitive performance during 2 consecutive examination rounds in relation to perfusion. Finally, we investigated whether associations were modified by baseline severity of white matter hyperintensities. Results: Of 4759 participants (median age 61.3 years, 55.2% women) with a median follow-up of 6.9 years, 123 participants developed dementia (97 Alzheimer disease). Lower cerebral perfusion was associated with higher risk of dementia (adjusted hazard ratio, 1.31; 95% confidence interval per standard deviation decrease, 1.07–1.61), similar for Alzheimer disease only, and unaltered by accounting for stroke. Risk of dementia with hypoperfusion was higher with increasing severity of white matter hyperintensities (with severe white matter hyperintensities; hazard ratio, 1.54; 95% confidence interval, 1.11–2.14). At cognitive reexamination after on average 5.7 years, lower baseline perfusion was associated with accelerated decline in cognition (global cognition: &bgr;=−0.029, P=0.003), which was similar after excluding those with incident dementia, and again most profound in individuals with higher volume of white matter hyperintensities (P value for interaction=0.019). Conclusions: Cerebral hypoperfusion is associated with accelerated cognitive decline and an increased risk of dementia in the general population.

[1]  R. Sacco,et al.  Brain health and shared risk factors for dementia and stroke , 2015, Nature Reviews Neurology.

[2]  A. Hofman,et al.  Association of Cerebral Microbleeds With Cognitive Decline and Dementia. , 2016, JAMA neurology.

[3]  Sterling C. Johnson,et al.  Macrovascular and microvascular cerebral blood flow in adults at risk for Alzheimer's disease , 2017, Alzheimer's & dementia.

[4]  W. Mali,et al.  Effect of age on cerebral blood flow: measurement with ungated two-dimensional phase-contrast MR angiography in 250 adults. , 1998, Radiology.

[5]  Laura Fratiglioni,et al.  A major role for cardiovascular burden in age-related cognitive decline , 2015, Nature Reviews Cardiology.

[6]  M. Dichgans,et al.  Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging , 2013, The Lancet Neurology.

[7]  M. Block,et al.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.

[8]  Ian Marshall,et al.  Cerebral blood flow in small vessel disease: A systematic review and meta-analysis , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  Truman R Brown,et al.  Linking hippocampal structure and function to memory performance in an aging population. , 2009, Archives of neurology.

[10]  M. Prince,et al.  World Alzheimer Report 2013 , 2014 .

[11]  Wiro J. Niessen,et al.  Multi-spectral brain tissue segmentation using automatically trained k-Nearest-Neighbor classification , 2007, NeuroImage.

[12]  Thorbjørn S. Engedal,et al.  Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  H. Markus,et al.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[14]  Jeffrey A. James,et al.  Incidental Cerebral Microbleeds and Cerebral Blood Flow in Elderly Individuals. , 2015, JAMA neurology.

[15]  Peter Carmeliet,et al.  Hypoxia and inflammation. , 2011, The New England journal of medicine.

[16]  A. Hofman,et al.  The Rotterdam Scan Study: design update 2016 and main findings , 2015, European Journal of Epidemiology.

[17]  J. C. Torre Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. , 2012 .

[18]  Salvatore Mazza,et al.  Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. , 2011, Journal of Alzheimer's disease : JAD.

[19]  Aad van der Lugt,et al.  Total Cerebral Blood Flow and Total Brain Perfusion in the General Population: The Rotterdam Scan Study , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  A. Hofman,et al.  Cerebral Vasoreactivity, Apolipoprotein E, and the Risk of Dementia: A Population-Based Study , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[21]  B. Zlokovic Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[22]  A. Hofman,et al.  Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study , 2005, Annals of neurology.

[23]  D. Drachman The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease , 2014, Alzheimer's & Dementia.

[24]  Maja A. A. Binnewijzend,et al.  Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. , 2013, Radiology.

[25]  Frieke M. A. Box,et al.  Reproducibility of total cerebral blood flow measurements using phase contrast magnetic resonance imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[26]  J. Detre,et al.  Assessment of cerebral blood flow in Alzheimer's disease by spin‐labeled magnetic resonance imaging , 2000, Annals of neurology.

[27]  C. Nicholson,et al.  Clearance systems in the brain-implications for Alzheimer disease. , 2015, Nature reviews. Neurology.

[28]  Don L. Armstrong,et al.  Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease , 2005, Nature Medicine.

[29]  Norbert Schuff,et al.  Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. , 2014, Brain : a journal of neurology.

[30]  A Hofman,et al.  Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly , 1999, Neurology.

[31]  H. Tomimoto,et al.  Chronic cerebral hypoperfusion and dementia , 2014 .

[32]  Walter H. Backes,et al.  Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging , 2016, Neurobiology of Aging.

[33]  Frederik Barkhof,et al.  Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease , 2016, European Radiology.

[34]  Brian J. Bacskai,et al.  Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer’s disease mouse models , 2013, Acta Neuropathologica.

[35]  N. Schuff,et al.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.

[36]  M. Prince,et al.  World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future , 2016 .

[37]  Burkhard Becher,et al.  Immune attack: the role of inflammation in Alzheimer disease , 2015, Nature Reviews Neuroscience.

[38]  Monique M. B. Breteler,et al.  The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.

[39]  Albert Hofman,et al.  The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study , 2015, BMC Medicine.

[40]  A. Hofman,et al.  The Bidirectional Association between Reduced Cerebral Blood Flow and Brain Atrophy in the General Population , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  F. Howe,et al.  Blood–brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[42]  Arne Møller,et al.  The capillary dysfunction hypothesis of Alzheimer's disease , 2013, Neurobiology of Aging.

[43]  H. Brodaty,et al.  ALZHEIMER'S DISEASE INTERNATIONAL , 1997, International journal of geriatric psychiatry.

[44]  Aad van der Lugt,et al.  Patterns of cognitive function in aging: the Rotterdam Study , 2014, European Journal of Epidemiology.

[45]  W. Mali,et al.  Combined Effect of Cerebral Hypoperfusion and White Matter Lesions on Executive Functioning – The SMART-MR Study , 2010, Dementia and Geriatric Cognitive Disorders.

[46]  S. Love,et al.  Pathophysiology of white matter perfusion in Alzheimer’s disease and vascular dementia , 2014, Brain : a journal of neurology.

[47]  Zhen Zhao,et al.  Establishment and Dysfunction of the Blood-Brain Barrier , 2015, Cell.

[48]  R Nick Bryan,et al.  Comparison of non-invasive MRI measurements of cerebral blood flow in a large multisite cohort , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.